CytomX Therapeutics, Inc. CTMX

2.70 (0.05) (1.82%) as of 25 Sep

Market cap: $599.2M
P/E: 0.0×

Follow CTMX

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

	Dec '16	Dec '17	Dec '18	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	Dec '25
Cash and Short Term Investments	181.94	374.11	436.13	296.15	316.12	305.23	193.65	174.51	100.62	137.05
Receivables	2.31	10.14	0.10	0.01	0.80	0.79	35.99	3.43	3.10	2.01
Other current assets	3.90	4.35	9.25	7.18	7.10	4.29	7.47	—	—	—
Total current assets	188.15	388.60	445.48	303.34	324.01	310.30	237.10	182.94	107.31	143.92
Property, Plant, Equpment (Net)	4.39	4.22	6.93	7.37	6.95	5.96	5.07	3.96	2.47	1.30
Goodwill and Intangible Assets (Total)	2.70	2.55	2.41	2.26	2.12	1.97	1.82	1.68	1.53	1.39
Long-term assets (Other)	3.89	2.27	2.29	2.93	3.09	1.82	0.94	1.00	1.09	1.56
Total non-current assets	10.98	9.04	11.63	37.95	34.65	29.11	23.79	18.86	13.23	7.65
Total Assets	199.13	397.64	457.11	341.28	358.66	339.41	260.89	201.79	120.53	151.57
Accounts Payable	6.60	4.21	5.13	4.16	3.00	2.82	2.81	1.46	1.09	1.30
Accrued Expenses	8.82	16.38	26.72	30.05	23.06	34.24	24.45	17.60	12.34	14.20
Current Part of Debt	—	—	—	2.81	3.20	3.62	4.08	4.59	—	—
Current Part of Taxes to Pay	—	0.00	13.34	0.00	—	—	—	—	—	—
Current Revenue (Deferred)	20.35	40.56	52.71	51.38	74.87	40.82	121.27	132.27	67.20	26.88
Total current liabilities	35.77	61.15	97.91	85.59	100.92	77.87	152.61	155.91	85.77	46.62
Non-current Revenue (Deferred)	83.80	264.70	225.27	178.86	186.26	243.94	180.06	80.05	26.86	1.59
Long Term Tax Liability (Deferred)	0.51	(0.51)	—	—	—	—	—	—	—	—
Non-current Liabilities (Other)	0.57	1.90	3.05	0.85	—	—	—	3.89	4.12	4.35
Total non-current liabilities	84.88	266.60	228.32	204.58	207.94	262.00	194.03	93.33	35.22	5.94
Total liabilities	120.65	327.75	326.23	290.17	308.86	339.87	346.64	249.24	120.99	52.56
Additional Paid In Capital	254.87	289.45	445.96	468.29	499.96	623.34	637.12	675.91	691.10	810.84
Common Stock (Net)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Retained Earnings	(176.37)	(219.46)	(314.98)	(417.23)	(450.11)	(623.56)	(722.88)	(723.45)	(691.58)	(711.95)
Common Equity (Total)	78.48	69.90	130.88	51.11	49.80	(0.46)	(85.75)	(47.45)	(0.46)	99.01
Shareholders Equity (Total)	78.48	69.90	130.88	51.11	49.80	(0.46)	(85.75)	(47.45)	(0.46)	99.01
Shareholders Equity and Liabilities (Total)	199.13	397.64	457.11	341.28	358.66	339.41	260.89	201.79	120.53	151.57
Shares (Common)	36.49	38.48	45.08	45.52	48.25	65.39	66.23	67.31	80.10	170.19
Shareholders Equity (Tangible)	75.78	67.34	128.48	48.85	47.69	(2.43)	(87.57)	(49.12)	(1.99)	97.62
Net Debt	(181.94)	(374.11)	(436.13)	(293.33)	(312.92)	(301.61)	(189.57)	(169.92)	(100.62)	(137.05)
Total Debt	—	—	—	2.81	3.20	3.62	4.08	4.59	—	—

Show all line items

In millions of $ except per-share values · columns are period end dates

Powerpack

Full quarterly history

Analyst estimates

Unlimited screener

Unlimited Excel

Unlimited follows

CytomX Therapeutics, Inc. CTMX